Provention Bio Inc. (PRVB) Prices 6.6M Share Common Offering at $14.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Pre-Open Movers 06/17: (WATT) (INWK) (GRPN) Higher; (CEMI) (ATNM) (NCLH) Lower (more...)
June 17, 2020 9:27 AM EDTToday's Pre-Open Stock Movers
Energous Corporation (Nasdaq: WATT) 66.5% HIGHER; announced a partnership with one of the worlds leading battery manufacturers in China, Grepow Battery. Energous and Grepow Battery are working together to develop batteries that are wirelessly charged via WattUp, a radio frequency (RF) based charging technology, for use in electronic devices in the commercial, industrial and medical industries.
Chembio Diagnostics (NASDAQ: CEMI) 60.4% LOWER; multiple downgrades
Aclaris Therapeutics, Inc. (NASDAQ:... More
After-Hours Movers 06/16: (INWK) (MGEN) (FLGT) Higher; (ATNM) (VOLT) (NCLH) Lower (more...)
June 16, 2020 5:20 PM EDTToday's After-Hours Stock Movers
InnerWorkings (NASDAQ: INWK) 39% HIGHER; reported Q1 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $261.4 million versus the consensus estimate of $267.98 million.
miRagen Therapeutics, Inc. (NASDAQ: MGEN) 37% HIGHER; scheduled to host a key opinion leaders (KOL) call regarding idiopathic pulmonary fibrosis (IPF) on Tuesday, June 23rd at 11 a.m. Eastern Time. The Company will also discuss encouraging new preclinical safety and efficacy data for its... More
Provention Bio Inc. (PRVB) Announces Proposed 5.5M Share Common Offering
June 16, 2020 4:02 PM EDTProvention Bio, Inc., (NASDAQ: PRVB) today announced that it has commenced an underwritten public offering of 5,500,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Provention Bio. In connection with the offering,... More
Provention Bio Inc. (PRVB) PT Raised to $26 at H.C. Wainwright
June 16, 2020 6:34 AM EDTH.C. Wainwright analyst Raghuram Selvaraju raised the price target on Provention Bio Inc. (NASDAQ: PRVB) to $26.00 (from $20.00) while maintaining a Buy rating.... More

